+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2021-2025

  • ID: 5008906
  • Report
  • September 2021
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • AllCells Corp.
  • bluebird bio Inc.
  • FUJIFILM Holdings Corp.
  • Lonza Group Ltd.
  • MEDIPOST Co. Ltd.
  • Merck and Co. Inc.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the hematopoietic stem cells transplantation (HSCT) market and it is poised to grow by $1.99 bn during 2021-2025, progressing at a CAGR of over 6% during the forecast period. The report on the hematopoietic stem cells transplantation (HSCT) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising number of HSCT and the availability of technologically advanced equipment.

The hematopoietic stem cells transplantation (HSCT) market analysis includes the type segment and geographic landscape.

The hematopoietic stem cells transplantation (HSCT) market is segmented as below:


By Type

  • Autologous HSCT
  • Allogeneic HSCT

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the increasing investments in the field of regenerative medicines as one of the prime reasons driving the hematopoietic stem cells transplantation (HSCT) market growth during the next few years.

The report on hematopoietic stem cells transplantation (HSCT) market covers the following areas:

  • Hematopoietic stem cells transplantation (HSCT) market sizing
  • Hematopoietic stem cells transplantation (HSCT) market forecast
  • Hematopoietic stem cells transplantation (HSCT) market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hematopoietic stem cells transplantation (HSCT) market vendors that include AllCells Corp., bluebird bio Inc., FUJIFILM Holdings Corp., Lineage Cell Therapeutics Inc., Lonza Group Ltd., MEDIPOST Co. Ltd., Merck and Co. Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and ThermoGenesis Holdings Inc. Also, the hematopoietic stem cells transplantation (HSCT) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AllCells Corp.
  • bluebird bio Inc.
  • FUJIFILM Holdings Corp.
  • Lonza Group Ltd.
  • MEDIPOST Co. Ltd.
  • Merck and Co. Inc.

Executive Summary

  • Market overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Type

  • Market segments
  • Comparison by Type
  • Autologous HSCT - Market size and forecast 2020-2025
  • Allogeneic HSCT - Market size and forecast 2020-2025
  • Market opportunity by Type

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AllCells Corp.
  • bluebird bio Inc.
  • FUJIFILM Holdings Corp.
  • Lineage Cell Therapeutics Inc.
  • Lonza Group Ltd.
  • MEDIPOST Co. Ltd.
  • Merck and Co. Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • ThermoGenesis Holdings Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits

  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Type - Market share 2020-2025 (%)
  • Comparison by Type
  • Autologous HSCT - Market size and forecast 2020-2025 ($ million)
  • Autologous HSCT - Year-over-year growth 2020-2025 (%)
  • Allogeneic HSCT - Market size and forecast 2020-2025 ($ million)
  • Allogeneic HSCT - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Type
  • Customer landscape
  • Market share By Geographical Landscape 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity By Geographical Landscape ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • AllCells Corp. - Overview
  • AllCells Corp. - Product and service
  • AllCells Corp. - Key offerings
  • AllCells Corp. - Key customers
  • AllCells Corp. - Segment focus
  • bluebird bio Inc. - Overview
  • bluebird bio Inc. - Business segments
  • bluebird bio Inc. - Key offerings
  • bluebird bio Inc. - Key customers
  • bluebird bio Inc. - Segment focus
  • FUJIFILM Holdings Corp. - Overview
  • FUJIFILM Holdings Corp. - Business segments
  • FUJIFILM Holdings Corp. - Key offerings
  • FUJIFILM Holdings Corp. - Key customers
  • FUJIFILM Holdings Corp. - Segment focus
  • Lineage Cell Therapeutics Inc. - Overview
  • Lineage Cell Therapeutics Inc. - Product and service
  • Lineage Cell Therapeutics Inc. - Key offerings
  • Lineage Cell Therapeutics Inc. - Key customers
  • Lineage Cell Therapeutics Inc. - Segment focus
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Business segments
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Key customers
  • Lonza Group Ltd. - Segment focus
  • MEDIPOST Co. Ltd. - Overview
  • MEDIPOST Co. Ltd. - Product and service
  • MEDIPOST Co. Ltd. - Key offerings
  • MEDIPOST Co. Ltd. - Key customers
  • MEDIPOST Co. Ltd. - Segment focus
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Key customers
  • Merck and Co. Inc. - Segment focus
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key offerings
  • Sanofi SA - Key customers
  • Sanofi SA - Segment focus
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product and service
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Takeda Pharmaceutical Co. Ltd. - Key customers
  • Takeda Pharmaceutical Co. Ltd. - Segment focus
  • ThermoGenesis Holdings Inc. - Overview
  • ThermoGenesis Holdings Inc. - Business segments
  • ThermoGenesis Holdings Inc. - Key offerings
  • ThermoGenesis Holdings Inc. - Key customers
  • ThermoGenesis Holdings Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AllCells Corp.
  • bluebird bio Inc.
  • FUJIFILM Holdings Corp.
  • Lonza Group Ltd.
  • MEDIPOST Co. Ltd.
  • Merck and Co. Inc.
The publisher recognizes the following companies as the key players in the global hematopoietic stem cells transplantation (HSCT) market: AllCells Corp., bluebird bio Inc., FUJIFILM Holdings Corp., Lineage Cell Therapeutics Inc., Lonza Group Ltd., MEDIPOST Co. Ltd., Merck and Co. Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and ThermoGenesis Holdings Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing investments in the field of regenerative medicines.`

According to the report, one of the major drivers for this market is the rising number of HSCT.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AllCells Corp.
  • bluebird bio Inc.
  • FUJIFILM Holdings Corp.
  • Lineage Cell Therapeutics Inc.
  • Lonza Group Ltd.
  • MEDIPOST Co. Ltd.
  • Merck and Co. Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • ThermoGenesis Holdings Inc.
Note: Product cover images may vary from those shown